Open 365 Days

Fasenra‎®

Also known as:
Benralizumab

An interleukin-5 receptor alpha-directed cytolytic monoclonal antibody (IgG1, kappa) indicated for the add-on maintenance treatment of patients with severe asthma aged 12 years and older, and with an eosinophilic.

ContactWasatch Infusion

Phone: (801) 577-7055
Fax: (888) 717-7578